Oxford Nanopore Technologies Ltd.
General information
Oxford Nanopore Technologies Ltd.
Edmund Halley Road
Gosling Building, Oxford Science Park
OX44DQ Oxford, England
United Kingdom
Contact person: Gordon Sanghera, Chief Executive Officer & Founder
Company main phone: +44 (845) 0347900
Company main fax: +44 (845) 0347901
Website: https://nanoporetech.com
Edmund Halley Road
Gosling Building, Oxford Science Park
OX44DQ Oxford, England
United Kingdom
Contact person: Gordon Sanghera, Chief Executive Officer & Founder
Company main phone: +44 (845) 0347900
Company main fax: +44 (845) 0347901
Website: https://nanoporetech.com
| Year founded: | 2005 |
| Source of foundation: | Spin-off from university |
| Name of foundation source: | University of Oxford |
| No. of employees: |
Worldwide: 1316 |
Corporate description / mission:
Oxford Nanopore Technologies Limited has developed a new generation of sensing technology that uses nanopores - nano-scale holes - embedded in high-tech electronics, to perform comprehensive molecular analyses. The GridION™ system and miniaturized MinION™ device are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows, and direct analysis of the molecule of interest.
Oxford Nanopore Technologies Limited has developed a new generation of sensing technology that uses nanopores - nano-scale holes - embedded in high-tech electronics, to perform comprehensive molecular analyses. The GridION™ system and miniaturized MinION™ device are designed to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows, and direct analysis of the molecule of interest.
State of ownership: Publicly listed on stock exchange
Headquarters: HQ: Yes
IPO (year): 2021
Headquarters: HQ: Yes
IPO (year): 2021
Remarks on ownership / listings
Oxford NanoLabs changed its name to Oxford Nanopore Technologies in May 2008.
Oxford NanoLabs changed its name to Oxford Nanopore Technologies in May 2008.
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
| Distribution: |
|
Summary Products / Services / Technologies
Description of products:
GridION™
MinION™
PromethION
SmidgION
etc.
GridION™
MinION™
PromethION
SmidgION
etc.
Special IP situation:
Oxford Nanopore has an intellectual property portfolio of more than 300 issued patents and patent applications in over 80 patent families.
Oxford Nanopore has an intellectual property portfolio of more than 300 issued patents and patent applications in over 80 patent families.
Technology used:
Oxford Nanopore Technologies Ltd is developing a disruptive, proprietary technology platform for the label-free analysis of single molecules.
Oxford Nanopore Technologies Ltd is developing a disruptive, proprietary technology platform for the label-free analysis of single molecules.
Financing details
Fiscal year (end of) 2025
| Revenues: | USD 299.91M | |
| R&D expenses: | USD 130.87M |
| Cash: | USD 242.58M | |
| No. of shares: | 972'516'815 |
© 2026 Biotechgate by Venture Valuation